4//SEC Filing
TardiMed Sciences LLC 4
Accession 0001104659-21-081618
CIK 0001504167other
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 6:49 PM ET
Size
7.5 KB
Accession
0001104659-21-081618
Insider Transaction Report
Form 4
TardiMed Sciences LLC
10% Owner
Transactions
- Sale
Common Stock, par value $0.001 per share
2021-06-14$1.27/sh−146,465$185,557→ 4,637,517 total - Sale
Common Stock, par value $0.001 per share
2021-06-15$1.26/sh−28,450$35,924→ 4,609,067 total
Footnotes (2)
- [F1]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.31, inclusive. The reporting person undertakes to provide to Timber Pharmaceuticals, Inc. ("Timber"), any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- [F2]The price represents the weighted average sales price for multiple transactions reported on this line. The prices of the transactions ranged from $1.26 to $1.28, inclusive. The reporting person undertakes to provide to Timber, any security holder of Timber, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
Documents
Issuer
Timber Pharmaceuticals, Inc.
CIK 0001504167
Entity typeother
IncorporatedCT
Related Parties
1- filerCIK 0001800690
Filing Metadata
- Form type
- 4
- Filed
- Jun 14, 8:00 PM ET
- Accepted
- Jun 15, 6:49 PM ET
- Size
- 7.5 KB